Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 27;13(23):1962.
doi: 10.3390/cells13231962.

Vascular Cognitive Impairment-The Molecular Basis and Potential Influence of the Gut Microbiota on the Pathological Process

Affiliations
Review

Vascular Cognitive Impairment-The Molecular Basis and Potential Influence of the Gut Microbiota on the Pathological Process

Piotr Olejnik et al. Cells. .

Abstract

Cognitive impairment is a major healthcare challenge worldwide, with vascular cognitive impairment (VCI) being its second leading cause after Alzheimer's disease. VCI is a heterogeneous group of cognitive disorders resulting from various vascular pathologies. Therefore, it is particularly difficult to determine its underlying cause and exact molecular basis. Nevertheless, the current understanding of the pathophysiological processes underlying VCI has changed and evolved in the last decades. The aim of this narrative review is to summarize the current state of knowledge on VCI pathogenesis and to analyze the potential role of the gut microbiota in this process, considering the most recent scientific reports and in accordance with the current understanding of these processes. Chronic cerebral hypoperfusion, which results in impaired blood supply, i.e., oxygen and nutrient deficiency, is the main underlying mechanism of VCI. Furthermore, chronic cerebral hypoperfusion triggers a cascade of molecular changes, starting with an energy imbalance, leading to glutamate excitotoxicity, acidotoxicity, and oxidative stress. Also, all of the above provoke the activation of microglia and the release of pro-inflammatory cytokines that recruit systemic immune cells and lead to their infiltration into the central nervous system, resulting in neuroinflammation. Blood-brain barrier dysfunction may occur at various stages of chronic cerebral hypoperfusion, ultimately increasing its permeability and allowing potentially toxic substances to enter the brain parenchyma. Gut microbiota and their metabolites, which have been identified in numerous inflammatory conditions, may also influence the pathophysiological processes of VCI.

Keywords: gut microbiota; molecular mechanism; vascular cognitive impairment; vascular dementia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The sequence of vascular cognitive impairment pathophysiology.
Figure 2
Figure 2
Chronic cerebral hypoperfusion leads to reduced cerebral blood flow (CBF), which then causes hypoxia. Moreover, hypoxia results in rapid depletion of adenosine triphosphate that triggers excitotoxicity and acidotoxicity. The pathophysiological changes described above lead to oxidative stress and further cellular damage. Thereafter, damage-associated molecular patterns (DAMPs) are released, triggering activation of microglia, which consequently release pro-inflammatory cytokines that exacerbate neuroinflammation. Finally, all of this causes endothelial dysfunction resulting in blood–brain barrier dysfunction and further deterioration of the whole process.
Figure 3
Figure 3
Gut microbiota may influence vascular cognitive impairment omnidirectionally. First, its role has been established in traditional vascular risk factors, such as atherosclerosis, diabetes mellitus, or hypertension. Second, dysbiosis leads to reduced levels of short-chain fatty acids (SCFAs) and elevated levels of trimethylamine N-oxide (TMAO), leading to blood–brain barrier dysfunction and chronic low-grade inflammatory processes.

Similar articles

Cited by

References

    1. Nichols E., Steinmetz J.D., Vollset S.E., Fukutaki K., Chalek J., Abd-Allah F., Abdoli A., Abualhasan A., Abu-Gharbieh E., Akram T.T., et al. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105–e125. doi: 10.1016/S2468-2667(21)00249-8. - DOI - PMC - PubMed
    1. Chang Wong E., Chang Chui H. Vascular Cognitive Impairment and Dementia. Contin. Lifelong Learn. Neurol. 2022;28:750–780. doi: 10.1212/CON.0000000000001124. - DOI - PMC - PubMed
    1. Rethemiotaki I. Global Prevalence of Cardiovascular Diseases by Gender and Age during 2010–2019. Arch. Med. Sci. Atheroscler. Dis. 2024;8:196–205. doi: 10.5114/amsad/176654. - DOI - PMC - PubMed
    1. Wolters F.J., Ikram M.A. Epidemiology of Vascular Dementia. Arterioscler. Thromb. Vasc. Biol. 2019;39:1542–1549. doi: 10.1161/ATVBAHA.119.311908. - DOI - PubMed
    1. Li R., Li R., Xie J., Chen J., Liu S., Pan A., Liu G. Associations of Socioeconomic Status and Healthy Lifestyle with Incident Early-Onset and Late-Onset Dementia: A Prospective Cohort Study. Lancet Healthy Longev. 2023;4:e693–e702. doi: 10.1016/S2666-7568(23)00211-8. - DOI - PubMed

MeSH terms

LinkOut - more resources